Hannah Deresiewicz
Contacto de Relaciones con Inversores en FORTY SEVEN, INC. .
Cargos activos de Hannah Deresiewicz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FORTY SEVEN, INC. | Contacto de Relaciones con Inversores | - | - |
| KALA BIO, INC. | Contacto de Relaciones con Inversores | - | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2013 | - |
Historial de carrera de Hannah Deresiewicz
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Hannah Deresiewicz
- Experiencia
